Ce rocher identifié par Perseverance fascine les scientifiques, car il présente une apparence jamais observée auparavant sur ...

Quebec Innovative Materials Corp. annonce la première découverte significative d'anomalies d'hydrogène naturel dans le sol et le gaz du Québec. 25/07 NE First phosphate confirme un important dépôt de ...

ROCHE HOLDINGS AG : JP Morgan toujours à vendre sur le dossier 26/09 ZD ROCHE HOLDINGS AG : Goldman Sachs toujours à vendre sur le dossier 26/09 ZD ROCHE HOLDINGS AG : Berenberg n'est pas ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in-class infused drug quickly became the best-selling treatment in a crowded multiple sclerosis (MS) market. Three years later ...

ASX chairman Damian Roche will retire next month after four years as head of the board of the sharemarket operator, a period marked by the failed roll-out of critical settlement and clearing ...